AKT1 and hepatocellular carcinoma: To address which NOTCH member took the key position during the progress of liver cancer, Huntzicker et al. used antibodies to specifically target NOTCH1-3 and JAG1 respectively in xenograft mouse model of primary HCC driven by AKT and N-RAS [78].